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ABSTRACT 
Background: In older people, quantification of risk of reattendance after ED discharge 
is important to provide adequate post ED discharge care in the community to 
appropriately targeted patients at risk.  
Methods: We reanalysed data from a prospective observational study, previously used 
for derivation of a nomogram for stratifying people aged 65 and older at risk for ED 
reattendance. We investigated the potential effect of comorbidity load and frailty by 
adding the Charlson or Elixhauser comorbidity index and a 10-item frailty measure 
from our data to develop four new nomograms.  Model I and model F built on the 
original nomogram by including the frailty measure with and without the addition of 
the Charlson comorbidity score; model E adapted for efficiency in the time-constrained 
environment of ED was without the frailty measure; and model P manually constructed 
in a purposeful stepwise manner and including only statistically significant variables. 
Areas under the ROC curve of models were compared. The primary outcome was any 
ED reattendance within 28 days of discharge. 
Results: Data from 1357 patients were used. The point estimate of the respective areas 
under ROC were 0.63 (O), 0.63 (I), 0.68 (E), 0.71 (P) and 0.63 (F). 
Conclusion: Addition of a comorbidity index to our previous model improves 
stratifying elderly at risk of ED reattendance. Our frailty measure did not demonstrate 
any additional predictive benefit.   
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INTRODUCTION 
There is strong clinical and research interest in identifying older patients at highest risk 
of early emergency department (ED) reattendance after discharge. To this end, a 
number of researchers have developed screening tools that attempt to predict certain 
adverse events after discharge. In the main, these tools have certain similarities: they 
report composite outcomes for an adverse event (such as death, loss of independent 
living and hospitalisation) and they dichotomise patients into high versus low risk.  
Systematic reviews published recently have concluded that the most well-known of 
these screening tools, the Identification of Seniors At Risk (ISAR) and the Triage Risk 
Stratification Tool (TRST), have quite limited predictive validity for composite adverse 
outcomes 1,2. An even more comprehensive review of existing instruments determined 
that there were no pragmatic, accurate, and reliable instruments for geriatric ED 
patients3.  
We have previously attempted to take a different path, developing a risk nomogram 
(figure 1) that measured reattendance risk only, and no other outcomes, and provided 
an estimated percentage chance of reattendance rather than a high/low risk dichotomy4. 
In a validation study in a separate population we showed our nomogram performed very 
well at stratifying patients, with a strong relationship between projected and measured 
reattendance risk by stratum5. Yet the overall predictive performance remained 
unacceptably low to be used as a standalone tool, with an area under receiver operator 
characteristic (AUROC) curve of 0.65. This is because individually most discharged 
patients have a small projected risk of reattendance, yet collectively the very low risk 
groups make up a numerically large number of reattendances. For example, under ideal 
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performance there will be six reattendances both from a group of 600 patients with a 
1% projected risk per patient, and a group of 12 patients with a 50% projected risk per 
patient.  
However, in considering this, we hypothesised that the low AUROC may also be 
because the nomogram is underestimating risk for those projected to be low risk. When 
modelling the original nomogram, we incorporated a comorbid condition such as heart 
failure, or an indicator of frailty such as weight loss, as an individual risk factor for 
reattendance to be modelled. However, most authors agree that the cumulative effect 
of multimorbidity and frailty is greater than the sum of its parts. We hypothesised that 
calculating a composite measure of comorbidity and frailty and recalibrating the 
nomogram may improve its overall predictive value. 
 
  
5 
 
 
METHODS 
Study cohort 
The original derivation cohort for the development of our nomogram was reanalysed 
for this study4. The cohort consisted of 1439 male and female patients aged 65 years or 
older who were discharged home from the emergency departments of two hospitals in 
Western Australia. Prior to discharge, patients underwent a thorough assessment by 
medical, nursing and allied health staff, and a suite of variables were recorded including 
those related to the acute presentation, patient demographics, comorbid status, markers 
of geriatric syndromes and frailty, and post discharge planning and referral.  
Participants who were unintentionally enrolled in the study more than once after 
presenting to different EDs were identified and the oldest record of ED visit retained as 
the index ED visit.  The study was approved by the respective hospital human research 
ethics committees. 
Outcome measure 
The primary outcome measure was any attendance at an ED (not just the ED in which 
the study was conducted) within 28 days of discharge from the index ED visit.  
Subsequent ED reattendance were identified by patient level linkage to the Emergency 
Department Data Collection, a state-wide administrative data collection of all public 
and private hospital EDs obtained from the Data Linkage Branch, Department of 
Health. 6  
Comorbidity and frailty indices 
To reanalyse the data we calculated two comorbidity indices, the Charlson7 and 
Elixhauser8 indices, and a modified version of a composite frailty measure. We used 
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the Australian modification of the International Classification of Diseases, version10 
(ICD-10-AM) codes related to the index ED visit and all person-level linked hospital 
inpatient records three years before the index ED visit to calculate the comorbidity 
indices. Both the Elixhauser and Charlson Comorbidity Index were coded using the 
Quan algorithm.9 
A review of available frailty indices was carried out using OneSearch, a platform that 
allows searching various library and online databases (MEDLINE & OVID 
simultaneously (http://guides.library.uwa.edu.au/onesearch).  Seventeen frailty indices 
were identified with at least 1 frailty-related variable in common with our dataset. Our 
data were unable to match an entire published frailty index. Therefore, we composed a 
10-item frailty measure, whilst excluding all frailty-related variables already appearing 
in the original nomogram or the comorbidity indices (Table 1).   
Table 1. Variables used for 10 item frailty measure 
Variable 
Weight loss greater than 5kg in last 6 months 
Mobility aids used 
Visual aids used 
Any urinary incontinence 
Any faecal incontinence 
Living alone 
Needing formal community support 
Needing informal community support 
Anxiety 
One or more falls in past 6 months 
 
Patient variables 
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Variables tested in the nomogram development were:  age, sex, history of ED use, 
history of recent hospital admission (within 10 days), comorbid conditions collected at 
index ED visit, triage category at index ED visit, history of multiple falls, history of 
weight loss, poor vision, history of alcohol misuse, diagnosis at index ED presentation, 
sum of Elixhauser comorbid conditions (excluding depression) and the Charlson 
comorbidity index (with or without malignancy) in recent past history, our composed 
10 item frailty measure, polypharmacy, current malignancy, current accommodation 
status, carer status and the Six-item Screener (SIS) cognition score. Polypharmacy was 
defined as taking six or more different medications. 
Statistical analysis 
Data were structured into the counting process format so that each participant had 28 
observations representing the 28 days from date of index ED presentation until the end 
of the follow-up period. A participant was not considered at risk of an ED admission 
while in hospital and was removed from the risk pool during each hospital stay (interval 
truncation).  Participants were censored at date of death if it occurred during the follow-
up period. 
Two types of time-to-event approaches were considered.  The first was as a single 
failure approach where factors that predict the rate of first ED revisit only were 
modelled. That is, once a participant experienced a first ED revisit, they were no longer 
considered at further risk.   The second approach was a multiple failure one where a 
participant remained the risk pool during the full 28 days and allowed to experience 
multiple ED revisits during follow-up.    
Flexible parametric proportional hazards models that used restricted cubic splines 
(Royston-Parmar models10) to describe the baseline hazard were constructed for each 
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of the prognostic models.  Baseline complexity was described using three degrees of 
freedom in each of the models. The original nomogram (O) plus four other prognostic 
factor combinations were chosen (Table 2).  
a. The original nomogram with the Charlson comorbidity index (minus malignancy 
as this featured already in the original nomogram) and the frailty index added but 
no other adjustments (I) 
b. A maximally efficient nomogram (E) 
c. A maximally predictive nomogram (P) 
d. The original nomogram with the frailty score added but no other adjustments (F) 
Table 2. Included variables of all modelled nomograms 
Available variables O I E P F 
Age x x x x x 
Gender x x   x 
Number of ED presentations in last year x x x x x 
Polypharmacy x x   x 
Malignancy x x   x 
Depression x x x x x 
CCT intervention x x   x 
SIS cognition score x x  x x 
Dementia   x   
Six or more falls in past 12 months   x x  
Visual problems   x x  
Hospital admission in last 10 days   x x  
Charlson score (minus malignancy)  x    
Charlson score    x   
Frailty score  x   x 
Elixhauser score (excluding depression)    x  
Presentation for fracture, DVT or gastroenteritis    x  
SIS, The six-item screening; CCT, patient seen by care coordination team in ED 
 
Some elements, such as age and depression, are common across the four models, 
whereas other elements of model O such as polypharmacy were excluded for models E 
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and P. Each were tested under both single and multiple failure analyses.   For the more 
complex prognostic models, the variables describing ED history and sum of Elixhauser 
comorbid conditions were transformed using fractional polynomials to improve model 
fit.  Receiver operating characteristic (ROC) curve analysis of the sensitivity and 
specificity for the prognosis of ED reattendance for each model was conducted. The 
degree variation was explained by each model was estimated by using Royston and 
Sauerbrei's R2D measure. The probabilities of ED reattendance were plotted against time 
at specified centiles of the distribution of the prognostic index where the 95th percentile 
corresponded to highest risk and lowest 5th percentile corresponded to lowest risk.  
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RESULTS 
After removing non-index records for 65 participants who were enrolled twice, there 
remained 1,357 study participants with an index ED presentation.  During the 28 days 
of follow-up, there were 322 ED revisits by 254 (19%) participants.   Most of the 
participants who had an ED revisit had just one ED revisit (n=202; 80%). Two 
participants each had five ED revisits during the 28 day follow-up.  
Participant factors tabulated by whether they experienced an ED revisit during follow-
up or not is shown in Table 3.  Most participant factors show a statistically significant 
difference in proportions by ED revisit status.   Participants with at least one ED revisit 
within 28 days were more likely to have a greater history of ED visits, take six or more 
medications, have depression, malignancy, dementia, a higher frailty score and 
comorbidity index score, have a history of a recent hospital admission, poor vision and 
have had CCT intervention.   
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Table 3.  Patient demographic and health summary by ED reattendance.  
  ED reattendance within 28 days  
  No  (n=1103)  Yes (n=254) p-value 
Age (years) Mean (SD) 77.7 8.1  79.8 8.1 <0.001 
 Median IQR) 77 71-84  80 74-86  
        
Sex Male 624 56.6  143 56.3 
0.937 
 Female 479 43.4  111 43.7 
        
Previous ED visits (n, %) None 842 76.5  166 64.6 
<0.001 
 1 172 15.6  38 14.8 
 2 47 4.3  22 8.6 
 3 29 2.6  15 5.8 
 4 4 0.4  10 3.9 
 5+ visits 7 0.6  5 2.0 
        
Hospital discharge No 1051 89.5  207 81.5 
0.001 
within last 10 days Yes 52 10.5  47 18.5 
        
Polypharmacy No 762 69.1  148 58.3 
0.001 
 Yes 341 30.9  106 41.7 
        
Depression No 1093 99.2  247 97.2 
0.010 
 Yes 9 0.8  7 2.8 
        
Malignancy No 1048 95.1  232 91.3 
0.019 
 Yes 54 4.9  22 8.7 
        
CCT intervention No 782 70.9  163 64.2 
0.036 
 Yes 321 29.1  91 35.8 
        
Charlson index score None 846 76.7  174 68.5 
0.010  1 to 3 208 18.9  65 25.6 
 4 or more 49 4.4  14 5.5 
        
Frailty score  Mean (SD) 2.8 1.8  3.2 1.9 0.001 
 Median (IQR) 2 1-4  3 1-5  
        
SIS cognition score Mean (SD) 5.2 0.1  4.7 0.1 <0.001 
 Median (IQR)       
        
Dementia No 1087 98.6  243 95.7 
0.002 
 Yes 15 1.9  11 4.3 
        
History of 6 or more falls No 1064 96.5  228 89.8 
<0.001 
 Yes 39 3.5  26 10.2 
        
Vision difficulties No 987 89.5  207 81.5 
<0.001 
 Yes 116 10.5  47 18.5 
SIS, The six-item screening; CCT, patient seen by care coordination team; SD, standard 
deviation; IQR, interquartile range 
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Each of the five time-to-event multivariable regression models listed in Table 2 were 
run for both single and multiple failure times.  Summary model discrimination 
measures are shown in Table 4. The point estimate of the respective AUROC were 0.63 
(O), 0.63 (I), 0.68 (E), 0.71 (P) and 0.63 (F). This suggests that the addition of a 
composite measure of frailty provided no benefit to the overall predictive power of the 
nomogram, but that comorbidity indices may yield modest improvement. An estimate 
of the variation in outcome explained by each model shows that it is generally low for 
all models.  The most predictive model P explains only 30% of the variation in ED 
revisits, although this is double the 15% explained by the original nomogram (O).  
Table 4.  Discrimination and explained variance measures 
 Area under ROC  R2D 
Model Estimate 95%CI  Estimate 95%CI 
Single failure      
O 0.63 0.60-0.66  0.15 0.09-0.21 
I 0.63 0.60-0.66  0.15 0.09-0.21 
E 0.68 0.65-0.71  0.24 0.17-0.30 
P 0.71 0.68-0.73  0.31 0.25-0.38 
F 0.63 0.60-0.66  0.15 0.09-0.21 
      
Multiple failure      
O 0.63 0.60-0.66  0.14 0.09-0.20 
I 0.63 0.60-0.66  0.14 0.10-0.20 
E 0.68 0.65-0.71  0.24 0.19-0.30 
P 0.70 0.67-0.73  0.31 0.25-0.36 
F 0.63 0.60-0.66  0.14 0.10-0.19 
 
The distribution of the prognostic index from the four models is visualised in Figure 1.  
The plots give an impression of the range of discrimination from each model and show 
what might happen to patients at the extremities and in the middle of the risk profiles.  
Model P shows the greatest discrimination, particularly in the high risk centiles, but 
discrimination in the middle and low ranges of the risk spectrum is less well defined. 
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[Insert Fig 1 here] 
Fig 1 Probability of ED reattendance stratified into 20 percentiles of risk score 
estimated by the original nomogram time-to-event model O and models I, E and P.  
Bold line represents the 50th centile 
 
 
DISCUSSION 
In a reanalysis of a large dataset of patients, the addition of a composite measure of 
comorbidity, but not frailty, increased the predictive performance of a discharge risk 
assessment nomogram.  The integration of a comorbidity index has improved the 
previously developed nomogram at the cost of increased complexity of this risk 
stratification tool. This modest improvement and the limited predictive validity of all 
other ED screening tools for older people once again demonstrates the complexity of 
predicting ED revisits in complex older people post discharge. 
Placing people into reattendance risk strata before discharge from ED has several 
potential advantages, particularly in selecting high risk patients for intensive follow up 
after discharge11. With the worldwide ageing population, ED encounters with frail and 
multimorbid patients will be more common12. Frailty is a medical syndrome of 
increased vulnerability to a stressor that makes recovery from an acute illness or injury 
less likely13. It is intuitive to believe that a discharged frail person may be more likely 
to return to ED after discharge, but this was not the case in our work. Reasons for this 
may include a) the most severely frail patients tend to be admitted rather than 
discharged; b) that those with recognised frailty already have increased home supports 
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to reduce hospitalisation risk; or c) our frailty measure was not sufficiently selective.  
Incorporation of other measures of frailty like grip strength14 or inflammatory, 
nutritional or clinical biomarkers may be helpful15. 
Review articles have concluded that no published tool is yet robust enough to predict 
adverse outcomes in older people after discharge16. Largely this is because of their poor 
specificity, with many false positives. A two-step screening method, combining a 
sensitive tool with a specific one, may be a way forward. Alternatively, tools for 
specific individual presenting problems, such as infection or heart failure, may improve 
the clinical utility. 
 
CONCLUSION 
Addition of multimorbidity but not frailty measures increases the accuracy of a 
discharge risk nomogram. 
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